Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,24560,48,6.35 [3.38-11.90],8.378212540942786e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",24596,47,5.97 [2.86-12.47],1.988485678359237e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,23920,49,3.84 [2.45-6.04],5.0790068172729325e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,21165,44,1.92 [1.47-2.52],1.8429098914219028e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,24596,47,5.90 [2.70-12.88],8.28463514360259e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,24756,49,3.84 [2.34-6.30],1.039290125733736e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,23951,47,3.83 [2.51-5.85],5.343396427463863e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,24560,48,2.97 [1.85-4.79],7.350204454557424e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,24385,49,4.14 [2.28-7.51],2.9619400722505465e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,20778,43,3.94 [2.42-6.43],4.02092867765556e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,24739,49,4.61 [2.65-8.03],6.276535774616488e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,24802,48,3.35 [2.26-4.98],2.184243223784699e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,21257,44,5.93 [3.70-9.50],1.404205935813703e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,24494,49,5.34 [2.95-9.67],3.3466193973589446e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,23529,47,4.27 [2.29-7.94],4.652741321696264e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,24072,47,4.93 [2.76-8.81],7.026399905851299e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,24797,49,3.88 [2.26-6.66],9.127508782177688e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,24476,47,6.68 [2.96-15.09],4.964407613491422e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,24596,47,9.91 [4.87-20.16],2.49658846716598e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,24519,48,5.22 [2.72-10.01],6.454489216104813e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,24647,47,0.23 [0.13-0.40],5.788696122946587e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,24596,47,1.93 [1.53-2.42],1.8906222330920323e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,24739,49,1.62 [1.33-1.97],1.478508237142613e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,24596,47,2.03 [1.59-2.58],1.0157584813368917e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,24722,48,4.21 [2.53-7.00],3.024168328871895e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,24450,48,4.88 [2.47-9.62],4.880387452621003e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,24307,49,4.40 [2.41-8.04],1.4739879333768504e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,23627,46,4.71 [2.73-8.15],2.8763375263701134e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,24797,49,5.27 [2.67-10.40],1.6660794466757152e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,24695,48,0.25 [0.15-0.42],2.3703524678355137e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,24494,48,0.26 [0.17-0.41],2.2328565098321754e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,24441,47,5.02 [2.87-8.75],1.3822305868358788e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,24691,48,2.21 [1.62-3.00],4.304610643918365e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,24494,48,3.94 [2.34-6.62],2.355796172035273e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24494,49,4.25 [2.26-7.98],6.814190292699244e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,24370,48,5.44 [2.99-9.90],2.856228857974625e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,24174,48,2.73 [1.84-4.06],7.006440408672847e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,24057,47,1.59 [1.33-1.91],3.0353567321862694e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,24057,47,5.25 [2.91-9.46],3.469212659690066e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,24560,48,5.50 [3.25-9.31],2.1081855653136914e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,24336,49,3.79 [2.46-5.84],1.4775638003484732e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,24494,49,0.23 [0.14-0.38],4.144832521323831e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,24385,49,1.59 [1.34-1.89],1.0361996940235881e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,21200,44,2.83 [1.89-4.24],4.917378895851957e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24476,47,2.45 [1.66-3.62],6.304997311573196e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,24754,48,2.84 [1.86-4.34],1.345896688334256e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,24473,47,5.78 [3.22-10.38],3.989413551137457e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,24337,47,5.77 [2.99-11.14],1.8123698712242909e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,24336,47,2.73 [1.79-4.17],3.384754797014499e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,24461,49,4.14 [2.24-7.63],5.677286721615638e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,24487,49,4.63 [2.42-8.87],3.753478002347582e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,23851,49,2.83 [2.00-4.00],4.305784901355904e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",23928,49,1.95 [1.51-2.52],3.0549856311759137e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,21200,44,2.55 [1.69-3.85],8.20343932741088e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,24385,49,2.08 [1.60-2.70],4.6210211157310376e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,21208,44,9.72 [3.80-24.85],2.038447524120369e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,24687,48,4.02 [2.70-6.00],8.410145115851124e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,24802,48,2.61 [1.75-3.91],2.7832162978503864e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24494,48,4.72 [2.48-8.99],2.370268215120103e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,24292,48,3.59 [2.13-6.07],1.7873501470274603e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,24797,49,7.88 [3.38-18.37],1.7729530410307547e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,21224,44,2.41 [1.70-3.41],8.037535368250389e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,24343,48,2.47 [1.76-3.45],1.4415235986804022e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,24797,49,2.26 [1.71-2.98],8.374296080902272e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,24797,49,2.20 [1.65-2.93],8.058122117722272e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,23878,46,4.65 [2.70-8.01],3.194512464709005e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,24515,49,0.22 [0.14-0.34],3.7489753297565576e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,21249,44,3.80 [2.13-6.78],6.207795395956034e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,24596,47,3.35 [2.15-5.25],1.111162030906721e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,24494,49,4.11 [2.42-6.96],1.565728474609135e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,23920,49,3.60 [2.42-5.36],2.8566185805020593e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,23920,49,4.07 [2.25-7.37],3.5850405174527784e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,24750,49,3.11 [1.91-5.05],4.921476896113528e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,24550,47,4.36 [2.59-7.36],3.1428652332476834e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,24515,49,6.71 [3.39-13.29],4.7793975090649896e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,24072,47,3.97 [2.16-7.30],8.591129179378377e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,24739,49,5.40 [2.65-11.01],3.4053879085793627e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20778,43,0.22 [0.12-0.41],1.5846329450141884e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24494,48,5.04 [2.73-9.33],2.4559751434999625e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24494,48,1.99 [1.48-2.66],4.193060280578002e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,24739,49,5.65 [2.64-12.09],8.148164430311546e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24754,48,5.51 [3.48-8.71],2.786996378462698e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,24739,49,2.94 [2.02-4.27],1.5415707975103985e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24348,49,3.16 [2.08-4.81],7.1196814541368e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,24091,47,4.82 [2.52-9.20],1.859102775013197e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,24531,48,7.39 [3.80-14.37],3.657718316508425e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,24456,48,3.56 [2.24-5.65],6.920320901390364e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,23214,46,3.69 [2.39-5.70],3.899531581355415e-09
